News
Video
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
GLP-1 RA drugs have made headlines for improving health — and for high costs. Compounded versions may be less expensive, but that is not the case with every drug. Scott Brunner, CAE, CEO of the Alliance for Pharmacy Compounding, explains the context of cost for compounded medicines.